Shanghai Labway (China) Today
| 301060 Stock | 11.19 0.06 0.53% |
PerformanceWeak
| Odds Of DistressLow
|
Shanghai Labway is trading at 11.19 as of the 26th of February 2025, a 0.53 percent decrease since the beginning of the trading day. The stock's open price was 11.25. Shanghai Labway has about a 22 % chance of experiencing some form of financial distress in the next two years of operation and did not have a very good performance during the last 90 trading days. The performance scores are derived for the period starting the 30th of August 2024 and ending today, the 26th of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Shanghai Labway is entity of China. It is traded as Stock on SHE exchange. The company has 400.52 M outstanding shares. More on Shanghai Labway Clinical
Moving together with Shanghai Stock
| 0.82 | 688103 | Kunshan Guoli Electronic | PairCorr |
| 0.8 | 688013 | Touchstone International | PairCorr |
| 0.7 | 301236 | iSoftStone Information | PairCorr |
Moving against Shanghai Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Shanghai Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Shanghai Labway's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Shanghai Labway or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Diagnostics & Research, Health Care (View all Sectors) | ||||
Shanghai Labway's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Shanghai Labway's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsShanghai Labway can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Shanghai Labway's financial leverage. It provides some insight into what part of Shanghai Labway's total assets is financed by creditors.
| |||||
Shanghai Labway Clinical (301060) is traded on Shenzhen Stock Exchange in China and employs 1,487 people. Shanghai Labway is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 4.4 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Shanghai Labway's market, we take the total number of its shares issued and multiply it by Shanghai Labway's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Shanghai Labway Clinical operates under Biotechnology sector and is part of Health Care industry. The entity has 400.52 M outstanding shares.
Shanghai Labway generates positive cash flow from operations, but has no cash available
Check Shanghai Labway Probability Of Bankruptcy
Ownership AllocationShanghai Labway Clinical shows a total of 400.52 Million outstanding shares. Shanghai Labway Clinical has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 61.87 % of Shanghai Labway outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Shanghai Ownership Details
Shanghai Labway Clinical Risk Profiles
Although Shanghai Labway's alpha and beta are two of the key measurements used to evaluate Shanghai Labway's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 2.91 | |||
| Semi Deviation | 3.18 | |||
| Standard Deviation | 4.11 | |||
| Variance | 16.92 |
Shanghai Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Shanghai Labway without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run ETFs Now
ETFsFind actively traded Exchange Traded Funds (ETF) from around the world |
| All Next | Launch Module |
Shanghai Labway Corporate Directors
| Weixiong Zeng | NonExecutive Directors | Profile | |
| Linjie Sun | Director Director | Profile | |
| Zhisen Mao | Deputy Director | Profile | |
| Jian Zhu | Employee Director | Profile |
Other Information on Investing in Shanghai Stock
Shanghai Labway financial ratios help investors to determine whether Shanghai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Shanghai with respect to the benefits of owning Shanghai Labway security.